Skip to main content
OpenTrials

Clinical trial condition

Lupus Nephritis

Explore clinical trials studying Lupus Nephritis. Study availability and eligibility vary by location and protocol.

161 public trials 48 recruiting studies
Refine in advanced search Browse all conditions

Lupus Nephritis trial results

Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

NCT06711887

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Circuit Clinical Orchard Park, New York, United States
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Santo André, São Paulo, Brazil
  • Novartis Investigative Site Guangzhou, Guangdong, China
View all 49 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

NCT05039619

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Loma Linda University health Loma Linda, California, United States
  • UCSF Benioff Childrens Hospital San Francisco, California, United States
  • Children's Hospital Colorado, Anchutz Medical Campus Aurora, Colorado, United States
  • Emory Children's Center Atlanta, Georgia, United States
View all 43 locations
View Trial Details
Recruiting

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

NCT07570862

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • Wallace Rheumatic Studies Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Miami Dermatology and Laser Research Miami, Florida, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis Health Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Health Gainesville, Florida, United States
View all 23 locations
View Trial Details
Recruiting

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

NCT07053800

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • State University of New York Upstate Medical Center (SUNY) Syracuse, New York, United States
  • Texas Transplant Institute San Antonio, Texas, United States
  • University General Hospital ATTIKON Athens, Greece
  • University General Hospital of Patras Pátrai, Greece
View all 15 locations
View Trial Details
Recruiting

A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

NCT07598396

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Clnica SER da Bahia Salvador, Estado de Bahia, Brazil
  • L2IP ?Instituto de Pesquisas Clínicas Ltda. Brasília, Federal District, Brazil
  • IPC MT Instituto de Pesquisas Clinicas do Mato Grosso Cuiab, Mato Grosso, Brazil
  • Complexo Hospitalar de Niteroi Niterói, Rio de Janeiro, Brazil
View all 21 locations
View Trial Details
Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

NCT07611214

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Purushotham & Akther Kotha MD, Inc. La Mesa, California, United States
  • Valerius Medical Group & Research Center of Greater Long Beach, Inc. Los Alamitos, California, United States
  • Swati Shah MD Rheumatology, LLC Jacksonville, Florida, United States
  • CTR Oakwater Orlando, Florida, United States
View all 27 locations
View Trial Details

Related conditions